Vitamin a shown to protect tiny Preemies' lungs
NCT ID NCT07577180
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving very low birth weight preterm infants (born at or before 32 weeks, weighing under 1250 grams) a weekly high-dose oral vitamin A supplement could reduce their risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease. The trial randomly assigned 209 babies to receive either the vitamin or standard care. The goal was to see if this simple, low-cost approach could lower the number of infants needing oxygen at 36 weeks and improve overall outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY DYSPLASIA (BPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kocaeli City Hospital
Köseköy, Kocaeli, 41060, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Video coaching from home: a new approach to help preterm babies catch up on motor skills
- Can a steroid shot into the windpipe protect preemies' lungs?
- Which breathing tube works best for preterm infants? a trial puts two options to the test
- Could a smartphone app help babies see better?
- Mother's scent may calm preterm infants' breathing
- Could a simple fat supplement protect preemie lungs?